Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1989 Jul;29(3):226–230. doi: 10.1007/BF00200000

Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies

David W Hoskin 1,✉, Jana Stankova 2, Stephen K Anderson 2, John C Roder 2,3
PMCID: PMC11038839  PMID: 2567211

Abstract

Binding of CD3-specific antibodies to the TcR-CD3 complex results in T cell activation without the need for occupation of the T cell receptor (TcR) by its ligand. Murine T cells activated in this manner will kill a broad range of tumor targets but not normal lymphoblasts. We report here that non-specific cytolytic activity can be induced in vivo by a single i.p. injection of nonlytic 145-2C11 anti-CD3 monoclonal antibody. At least three populations of effector cells are activated in these mice. These are non-MHC(major histocompatibility complex) restricted cytotoxic T lymphocytes, activated natural killer cells, and lymphokine-activated killer cells. Anti-CD3 treatment is effective in significantly reducing the number of lung tumor nodules which form in mice inoculated with oncogenic ras-transfected syngeneic 10T1/2 fibroblasts. Anti-CD3-activated killer cells may, therefore, find a future role in cancer immunotherapy.

Keywords: Natural Killer, Major Histocompatibility Complex, Natural Killer Cell, Killer Cell, Lung Metastasis

References

  • 1.Fuyama S, Yamamoto H, Fujii Y, Arai S. Mechanism of in vivo generation of cytotoxic effector cells against tumors in tumor-bearing mice. Cancer Res. 1986;46:5548. [PubMed] [Google Scholar]
  • 2.Henney CS, Kuribayashi K, Kern DE, Gillies S. Interleukin-2 augments natural killer cell activity. Nature. 1981;291:335. doi: 10.1038/291335a0. [DOI] [PubMed] [Google Scholar]
  • 3.Hoskin DW, Stankova J, Anderson SK, Roder JC (1989) A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine activated killer (LAK) cells. Int J Cancer (in press) [DOI] [PubMed]
  • 4.Johnson PW, Trimble WS, Hozumi N, Roder JC. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells. J Immunol. 1987;138:3996. [PubMed] [Google Scholar]
  • 5.Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA. 1987;84:1374. doi: 10.1073/pnas.84.5.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Liu MA, Nussbaum SR, Eisen HN. Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells. Science. 1988;239:395. doi: 10.1126/science.3257303. [DOI] [PubMed] [Google Scholar]
  • 7.Merluzzi VJ, Smith MD, Last-Barney K. Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cells. Cell Immunol. 1986;100:563. doi: 10.1016/0008-8749(86)90054-7. [DOI] [PubMed] [Google Scholar]
  • 8.Meuer SC, Hodgdon JC, Hussey RE, Potentis JP, Schlossman SF, Reinhertz EL. Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med. 1983;158:988. doi: 10.1084/jem.158.3.988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Meuer SC, Hussey RE, Cantrell DA, Hodgdon JC, Schlossman SF, Smith KA, Reinhertz EL. Triggering of the T3-Ti antigen receptor complex results in clonal T cell proliferation through an interleukin-2-dependent autocrine pathway. Proc Natl Acad Sci USA. 1984;81:1509. doi: 10.1073/pnas.81.5.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Muul LM, Spiess PJ, Director EP, Rosenberg SA. Identification of specific cytolytic immune responses against autologous tumor in human cells bearing malignant melanoma. J Immunol. 1987;138:989. [PubMed] [Google Scholar]
  • 11.Oettgen HC, Terhorst C. The T cell receptor-T3 complex and T lymphocyte activation. Human Immunol. 1987;18:187. doi: 10.1016/0198-8859(87)90084-x. [DOI] [PubMed] [Google Scholar]
  • 12.Ostensen ME, Thiele DL, Lipsky PE. Tumor necrosis factor-alpha enhances cytolysis of human natural killer cells. J Immunol. 1987;138:4185. [PubMed] [Google Scholar]
  • 13.Pahar RS, Lala PK. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin-2. J Exp Med. 1987;165:14. doi: 10.1084/jem.165.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pollack SB, Emmons SL. An NK-associated antigen detected with NZB anti-Balb/c serum. J Immunol. 1982;129:2277. [PubMed] [Google Scholar]
  • 15.Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. Quantitation of natural killer (NK) cell activity. J Clin Immunol. 1981;1:51. doi: 10.1007/BF00915477. [DOI] [PubMed] [Google Scholar]
  • 16.Roder JC, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 1979;278:451. doi: 10.1038/278451a0. [DOI] [PubMed] [Google Scholar]
  • 17.Rosenberg SA, Lotze MT. Cancer immunotherapy using interleukin-2 and interleukin-2 activated lymphocytes. Annu Rev Immunol. 1986;4:681. doi: 10.1146/annurev.iy.04.040186.003341. [DOI] [PubMed] [Google Scholar]
  • 18.Rosenberg SA, Mule JJ, Spiess PJ, Reichert CM, Schwarz SL. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high dose recombinant IL-2. J Exp Med. 1985;161:1169. doi: 10.1084/jem.161.5.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rosenstein M, Yron I, Kaufman Y, Rosenberg SA. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin-2. Cancer Res. 1984;44:1546. [PubMed] [Google Scholar]
  • 20.Samelson LE, Harford JB, Klausner RD. Identification of the components of the murine T cell antigen receptor complex. Cell. 1985;43:223. doi: 10.1016/0092-8674(85)90027-3. [DOI] [PubMed] [Google Scholar]
  • 21.Stankova J, Hoskin DW, Roder JC (1989) Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations. Cell Immunol (in press) [DOI] [PubMed]
  • 22.Stitz LJ, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J Immunol. 1986;136:4674. [PubMed] [Google Scholar]
  • 23.Thorgeirsson UP, Turpeeniemi-Hujanon T, Williams JE, Westin EJ, Heilman CA, Talmadge JE, Liotta LA. NIH/3T3 cells transfected with human DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol. 1985;5:529. doi: 10.1128/mcb.5.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES